Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 5.41% is 12% below its 5-year average of 6.18%, around the middle of its 5-year range (2.50%–11.66%).
22.54% above its 12-month average of 4.41%.
Annual fiscal-year return on assets; no daily interpolation. Historical series through 2025-12-31.
RETURN ON ASSETS (ROA)
5.41%
RETURN ON ASSETS (ROA) AVG TTM
4.41%
RETURN ON ASSETS (ROA) AVG 3Y
4.42%
RETURN ON ASSETS (ROA) AVG 5Y
6.18%
RETURN ON ASSETS (ROA) AVG 10Y
5.72%
RETURN ON ASSETS (ROA) AVG 15Y
6.51%
RETURN ON ASSETS (ROA) AVG 20Y
7.48%
CURRENT VS TTM AVG
+22.54%
CURRENT VS 3Y AVG
+22.40%
CURRENT VS 5Y AVG
-12.48%
CURRENT VS 10Y AVG
-5.49%
CURRENT VS 15Y AVG
-16.95%
CURRENT VS 20Y AVG
-27.67%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+5.25%
vs the sector median at left
Labcorp Holdings Inc.
Market Cap
$25.55B
Return on Assets (ROA)
5.41%
TTM Avg
4.41%
3Y Avg
4.42%
5Y Avg
6.18%
Market Cap
$25.94B
Return on Assets (ROA)
6.27%
TTM Avg
5.75%
3Y Avg
6.24%
5Y Avg
8.30%
Market Cap
$26.14B
Return on Assets (ROA)
24.67%
TTM Avg
25.02%
3Y Avg
24.63%
5Y Avg
23.85%
Market Cap
$24.62B
Return on Assets (ROA)
20.48%
TTM Avg
9.54%
3Y Avg
8.43%
5Y Avg
7.44%
Market Cap
$24.37B
Return on Assets (ROA)
13.86%
TTM Avg
12.54%
3Y Avg
14.20%
5Y Avg
14.86%
Market Cap
$24.30B
Return on Assets (ROA)
-8.40%
TTM Avg
-3.96%
3Y Avg
9.16%
5Y Avg
17.06%
Market Cap
$28.88B
Return on Assets (ROA)
4.27%
TTM Avg
5.83%
3Y Avg
5.87%
5Y Avg
14.86%
Market Cap
$21.10B
Return on Assets (ROA)
18.16%
TTM Avg
16.59%
3Y Avg
14.73%
5Y Avg
13.22%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.55B | 5.41% | 4.41% | 4.42% | 6.18% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.94B | 6.27% | 5.75% | 6.24% | 8.30% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.14B | 24.67% | 25.02% | 24.63% | 23.85% |
| Incyte Corporation (INCY)vs › | $24.62B | 20.48% | 9.54% | 8.43% | 7.44% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.37B | 13.86% | 12.54% | 14.20% | 14.86% |
| BioNTech SE (BNTX)vs › | $24.30B | -8.40% | -3.96% | 9.16% | 17.06% |
| Medline Inc. (MDLN)vs › | $27.51B | 1.76% | 3.17% | 1.75% | 1.75% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.88B | 4.27% | 5.83% | 5.87% | 14.86% |
| United Therapeutics Corporation (UTHR)vs › | $21.10B | 18.16% | 16.59% | 14.73% | 13.22% |
| Waters Corporation (WAT)vs › | $30.54B | 0.67% | 13.34% | 15.53% | 17.15% |
ROA
5.4%
ROE
11.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.77% |
| 2024-12-31 | 4.06% |
| 2023-12-31 | 2.50% |
| 2022-12-31 | 6.35% |
| 2021-12-31 | 11.66% |
| 2020-12-31 | 7.75% |
| 2019-12-31 | 4.57% |
| 2018-12-31 | 5.46% |
| 2017-12-31 | 7.65% |
| 2016-12-31 | 5.14% |
| 2015-12-31 | 3.06% |
| 2014-12-31 | 7.00% |
| 2013-12-31 | 8.26% |
| 2012-12-31 | 8.56% |
| 2011-12-31 | 8.42% |
| 2010-12-31 | 9.02% |
| 2009-12-31 | 11.23% |
| 2008-12-31 | 9.95% |
| 2007-12-31 | 10.92% |
| 2006-12-31 | 10.79% |
| 2005-12-31 | 9.96% |
| 2004-12-31 | 10.08% |
| 2003-12-31 | 9.40% |
| 2002-12-31 | 9.75% |
| 2001-12-31 | 9.30% |
| 2000-12-31 | 6.73% |
| 1999-12-31 | 4.11% |
| 1998-12-31 | 4.19% |
| 1997-12-31 | -6.45% |
| 1996-12-31 | -8.01% |
